Action 603392 BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Actions

603392

CNE100004090

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
68,26 CNY +7,67% Graphique intraday de Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. +2,31% -9,14%
25/04 Beijing Wantai Biological Pharmacy Enterprise Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
29/03 Les bénéfices de Wantai BioPharm pour 2023 chutent de 74 % en raison de la baisse des revenus ; les actions chutent de 3 %. MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Wantai Biological's Phase 3 Trials for Nine-Valent HPV Vaccine Yields Performed 'As Expected'
Wantai BioPharm's 2023 Profit Drops 74% on Revenue Drop; Shares Slump 3%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Wantai Biological Pharmacy Predicts Up to 75% Profit Decline in 2023
Sinovac Halts Production of COVID-19 Vaccine as Demand Wanes
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. announces an Equity Buyback for CNY 400 million worth of its shares.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. authorizes a Buyback Plan.
Wantai Biological Pharmacy's Profit Drops 36.8% in H1
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Wantai Biological Pharmacy’s Profit Slides 6.5% in Q1 as Revenue Falls 9%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Wantai BioPharm Enrolls First Subjects for Pneumonia Vaccine Trial
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Tranche Update on Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s Equity Buyback Plan announced on August 6, 2022.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s Equity Buyback announced on August 6, 2022, has expired with 1,585,320 shares, representing 0.17% for CNY 200.17 million.
Las acciones chinas revierten las ganancias iniciales y terminan a la baja por tercera sesión -- Market Talk
China's super-rich see fortunes plunge as economy slows
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 603392
  4. Actualités Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  5. Autres langues